EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 50 / No 1 (March 2018) J Extra Corpor Technol, 50 1 (2018) 30-37 References
Free Access
Issue
J Extra Corpor Technol
Volume 50, Number 1, March 2018
Page(s) 30 - 37
DOI https://doi.org/10.1051/ject/201850030
Published online 15 March 2018
  1. Bembea MM, Schwartz JM, Shah N, et al. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J. 2013;59:63–8. [CrossRef] [PubMed] [Google Scholar]
  2. Annich G, Adachi I Anticoagulation for pediatric mechanical circulatory support. Pediatr Crit Care Med. 2013;14(Suppl 1):S37–42. [CrossRef] [PubMed] [Google Scholar]
  3. Extracorporeal Life Support Organization. ELSO Anticoagulation Guideline. 2015 Available at: http://www.elso.org/Portals/0/Files/elsoanticoagulationguideline8-2014-table-contents.pdf. Accessed March 11, 2016. [Google Scholar]
  4. Oliver WC Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth. 2009;13:154–75. [CrossRef] [PubMed] [Google Scholar]
  5. Baird CW, Zurakowski D, Robinson B, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival. Ann Thorac Surg. 2007;83:912–9, discussion 9–20. [CrossRef] [PubMed] [Google Scholar]
  6. Sievert A, Uber W, Laws S, et al. Improvement in long-term ECMO by detailed monitoring of anticoagulation: A case report. Perfusion. 2011;26:59–64. [CrossRef] [PubMed] [Google Scholar]
  7. Smythe MA, Koerber JM, Nowak SN, et al. Correlation between activated clotting time and activated partial thromboplastin times. Ann Pharmacother. 2002;36:7–11. [CrossRef] [PubMed] [Google Scholar]
  8. Reiner JS, Coyne KS, Lundergan CF, et al. Bedside monitoring of heparin therapy: Comparison of activated clotting time to activated partial thromboplastin time. Cathet Cardiovasc Diagn. 1994;32:49–52. [CrossRef] [PubMed] [Google Scholar]
  9. Srinivasan D, Watzak B Anticoagulant use in real time. J Pharm Pract. 2013;26:270–9. [CrossRef] [PubMed] [Google Scholar]
  10. Nagle EL, Dager WE, Duby JJ, et al. Bivalirudin in pediatric patients maintained on extracorporeal life support. Pediatr Crit Care Med. 2013;14:e182–8. [CrossRef] [PubMed] [Google Scholar]
  11. Ranucci M, Ballotta A, Kandil H, et al. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. Crit Care. 2011;15:R275. [CrossRef] [PubMed] [Google Scholar]
  12. Pieri M, Agracheva N, Bonaveglio E, et al. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: A case-control study. J Cardiothorac Vasc Anesth. 2013;27:30–4. [CrossRef] [PubMed] [Google Scholar]
  13. Riley JB, Schears GJ, Nuttall GA, et al. Coagulation parameter thresholds associated with non-bleeding in the eighth hour of adult cardiac surgical post-cardiotomy extracorporeal membrane oxygenation. J Extra Corpor Technol. 2016;48:71–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Fawcett T An introduction to ROC analysis. Pattern Recognit Lett. 2006;27:861–74. [CrossRef] [Google Scholar]
  15. Nankervis CA, Preston TJ, Dysart KC, et al. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. ASAIO J. 2007;53:111–4. [CrossRef] [PubMed] [Google Scholar]
  16. Urlesberger B, Zobel G, Zenz W, et al. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr. 1996;129:264–8. [CrossRef] [PubMed] [Google Scholar]
  17. Agati S, Ciccarello G, Salvo D, et al. Use of a novel anticoagulation strategy during in a pediatric population: Single-center experience. ASAIO J. 2006;52:513–6. [PubMed] [Google Scholar]
  18. Sulkowski JP, Preston TJ, Cooper JN, et al. Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation. J Extra Corpor Technol. 2014;46:69–76. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  19. Zou KH Statistical Evaluation of Diagnostic Performance: Topics in ROC Analysis. Boca Raton, FL: CRC Press; 2012. [Google Scholar]
  20. Niebler RA, Christensen M, Berens R, et al. Antithrombin replacement during extracorporeal membrane oxygenation. Artif Organs. 2011;35:1024–8. [CrossRef] [PubMed] [Google Scholar]
  21. Bolliger D, Zenklusen U, Tanaka KA Point-of-care coagulation management algorithms during ECMO support: Are we there yet? Minerva Anestesiol. 2016;82:1000–9. [PubMed] [Google Scholar]
  22. Zavadil DP, Stammers AH, Willett LD, et al. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol. 1998;30:83–90. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.